It was already shown that that inflammatory visceral fat accelerated atherosclerosis in apoE−∕−, possibly due to increase in MCP-1 since a pharmacological approach capable of reducing MCP-1 was efficient in reducing atherosclerosis in this model (Ohman et al., 2008). The gene discussed is CCL2; the disease is atherosclerosis.